Birdwatch Note
2023-01-26 16:43:22 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Prior to approval, the FDA, Pfizer, and Moderna stated publicly that "data are limited to assess the effect of the vaccine against transmission of SARS-CoV-2 from individuals who are infected despite vaccination." Pfizer, December 10, 2020: https://www.fda.gov/media/144245/download#page=48 Moderna, December 17, 2020: https://www.fda.gov/media/144434/download#page=49
Written by 92B6C4F354B863069D8FDCFCE28AD9A700129A6CA43609CBA4A68E9ECA8E55AA
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1618345146516381698
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1618650816755146754
- noteId - 1618650816755146754
- participantId - 92B6C4F354B863069D8FDCFCE28AD9A700129A6CA43609CBA4A68E9ECA8E55AA
- noteAuthorParticipantId -
- createdAtMillis - 1674751402454
- tweetId - 1618345146516381698
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Prior to approval, the FDA, Pfizer, and Moderna stated publicly that "data are limited to assess the effect of the vaccine against transmission of SARS-CoV-2 from individuals who are infected despite vaccination." Pfizer, December 10, 2020: https://www.fda.gov/media/144245/download#page=48 Moderna, December 17, 2020: https://www.fda.gov/media/144434/download#page=49
Note Ratings
rated at | rated by | |
2023-01-26 11:46:33 -0600 | 109A00CD19C4EA0D8FF123D71784EEDC36DDFB9B6ADFABE4FA1023D02212F9B5 | Rating Details |
2023-01-27 09:34:07 -0600 | 251AC165CB5ED83F4E14DDCD4B8093F263B74DF7BAD439D346626E95C30F3D4B | Rating Details |
2023-01-26 14:58:24 -0600 | 2C0C323337CADA4A449209AD8ECF2954421020C33C0FDAF5CAA4DD9CD50A4B60 | Rating Details |
2023-01-26 20:38:09 -0600 | 2D859468E6ACF0CAAC1219D3C6C6FF4C44A8DA8F794B0E1E9D2711B8F2C62936 | Rating Details |
2023-01-26 16:12:43 -0600 | 2DE0FEC07E33D5F2B6E315DA8EF5A82B60CFC6B87E29A8047161EC7E4A45269A | Rating Details |
2023-01-26 11:18:02 -0600 | 315046F152AF8280D54473F7FBD31897AC05369971A0BE954A1E55C32CF81785 | Rating Details |
2023-01-26 12:52:12 -0600 | 3440E327FFC09396E77E3C806B2CE63500A27905ABDA4DA599C2EFB3935307B4 | Rating Details |
2023-01-26 13:38:01 -0600 | 35E7925D51465928DBF10B26FB4B5EFDFDAD18017D6D63AA4111A8F97E752360 | Rating Details |
2023-01-26 11:54:11 -0600 | 3E43C30DFEEF19A4BA0EFE1E78A730455FA07A446BE71F2B8324CB307921EAB8 | Rating Details |
2023-01-29 18:04:48 -0600 | 3E6159020CC0DF5D00799DA1B18015AFBDA02FD51E440BBA230058FCD4E5ABF3 | Rating Details |
2023-01-26 10:55:19 -0600 | 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 | Rating Details |
2023-01-26 12:46:20 -0600 | 464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858 | Rating Details |
2023-01-28 22:40:36 -0600 | 4B39B968A299CD97FBA9FA1987C60E5761E0C1D7F4DE940C9E38F94F2BA82619 | Rating Details |
2023-01-26 14:45:06 -0600 | 4DF1CDFBEA3F6DE525FEEC58EEAF593D6DE2475010A316ED6876FA4CA230339A | Rating Details |
2023-01-26 11:03:21 -0600 | 4EA541A52F0A2FFA141E9EEC01E8F1EDC92ECAF672EC87DAB3D3CC1557A7AFD0 | Rating Details |
2023-02-11 07:43:27 -0600 | 5F70567B58C0AD8B38AE064172F7358F84DA61D6E07139A62A16F57A4EBA2A57 | Rating Details |
2023-01-26 13:55:13 -0600 | 62D26DA830555FDD1E00DD0ADDB3CC4AF4A77E3D5F9611454BF5A8815AF190B7 | Rating Details |
2023-01-26 12:30:11 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
2023-01-26 12:15:47 -0600 | 7ECA71D6724C9005F829CB1820CE3AE07F842024026D18DC1A5969D8278D1D50 | Rating Details |
2023-01-26 11:44:04 -0600 | 803CEE394E0F3E70D4176A8A2D86F197E68B4CD82367AF3F816B5669B0545937 | Rating Details |
2023-01-27 14:23:32 -0600 | 992932B0527A672C23AE61796C01072F45C13496756A150528BB74653898B6D4 | Rating Details |
2023-01-26 14:15:27 -0600 | 9DD80EA78E43B1B06FA282352A643A4BA02629CFF54F39CA4B2B8480F70A87B5 | Rating Details |
2023-01-26 13:26:22 -0600 | A13FA4AD54A1E0C11CCCFB931FC6B53D050FA41546CFC2F82A4B3E7640CB8A1C | Rating Details |
2023-01-26 15:23:20 -0600 | AC22A04AF90D68BA4A27C6EAF3E87E9418B141116CD03C0F0E4646FBBAADB25E | Rating Details |
2023-01-26 13:41:19 -0600 | AE8620EA2172FC9C11B34908521FCBAA482CEADC6B5A2CAC379F1E133CA48B09 | Rating Details |
2023-01-27 07:00:55 -0600 | B04FB014FD7A6927D8AB07FBFB95A39262F7E8C68AD5F481CF7A7343B63BB223 | Rating Details |
2023-01-26 14:18:42 -0600 | B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A | Rating Details |
2023-01-26 14:18:42 -0600 | B483F9C619AF60464043F7ACD847EBDAF0FEAF04E871DD0AE68077698B2F93F1 | Rating Details |
2023-01-26 11:43:35 -0600 | B6484B57FB523BBBB567CEB5716D0D6D0D2B80A59B6F17A8C42694894E0A8A31 | Rating Details |
2023-01-26 13:29:10 -0600 | B70A86285499C51D03E95258C2545AC189F7C7E661F5D0DDBCF584E3C3043ADE | Rating Details |
2023-01-26 16:44:42 -0600 | B9A9382D9039D0A1D4EF6385C72450F92C6E52A1B4D5AF9A7C20E0465A939DFB | Rating Details |
2023-01-26 18:24:52 -0600 | C035D750AB8B340BF49F5276E70A2C3A8A302DFF0D6C9DA3A98A5C9AF54F1FBC | Rating Details |
2023-01-26 18:45:59 -0600 | E2F56F92FCFE1099A1FF9A7E6E291D585F0800B13B4C8E7B290D2E06512C6E58 | Rating Details |
2023-01-26 17:56:30 -0600 | E7A599E5D7F73514A6CF22F90DDDA429821E331DE4D41B5D9AC074450726CF34 | Rating Details |
2023-01-26 11:44:49 -0600 | ED14DF347014BA9E565B82654064A1E63506FE5BD6D0CBCEDBBAFFB12DF9F057 | Rating Details |
2023-01-26 11:43:35 -0600 | Rating Details | |
2023-01-26 13:26:22 -0600 | Rating Details | |
2023-01-26 10:55:19 -0600 | Rating Details | |
2023-01-26 17:56:30 -0600 | Rating Details | |
2023-01-26 16:12:43 -0600 | Rating Details | |
2023-01-28 22:40:36 -0600 | Rating Details | |
2023-01-26 14:15:27 -0600 | Rating Details | |
2023-01-26 13:55:13 -0600 | Rating Details | |
2023-01-26 11:18:02 -0600 | Rating Details | |
2023-01-26 15:23:20 -0600 | Rating Details | |
2023-01-26 18:45:59 -0600 | Rating Details | |
2023-01-29 18:04:48 -0600 | Rating Details | |
2023-02-11 07:43:27 -0600 | Rating Details | |
2023-01-27 14:23:32 -0600 | Rating Details | |
2023-01-26 11:44:04 -0600 | Rating Details | |
2023-01-26 12:30:11 -0600 | Rating Details | |
2023-01-26 13:41:19 -0600 | Rating Details | |
2023-01-26 12:52:12 -0600 | Rating Details | |
2023-01-27 07:00:55 -0600 | Rating Details | |
2023-01-26 12:46:20 -0600 | Rating Details | |
2023-01-27 09:34:07 -0600 | Rating Details | |
2023-01-26 11:54:11 -0600 | Rating Details | |
2023-01-26 14:18:42 -0600 | Rating Details | |
2023-01-26 16:44:42 -0600 | Rating Details | |
2023-01-26 20:38:09 -0600 | Rating Details | |
2023-01-26 13:38:01 -0600 | Rating Details | |
2023-01-26 14:58:24 -0600 | Rating Details | |
2023-01-26 11:46:33 -0600 | Rating Details | |
2023-01-26 11:44:49 -0600 | Rating Details | |
2023-01-26 11:03:21 -0600 | Rating Details | |
2023-01-26 18:24:52 -0600 | Rating Details | |
2023-01-26 14:45:06 -0600 | Rating Details | |
2023-01-26 12:15:47 -0600 | Rating Details | |
2023-01-26 14:18:42 -0600 | Rating Details | |
2023-01-26 13:29:10 -0600 | Rating Details | |
2023-07-11 10:54:19 -0500 | Rating Details | |
2023-07-11 05:39:44 -0500 | Rating Details | |
2023-07-11 05:32:52 -0500 | Rating Details | |
2023-07-11 04:47:09 -0500 | Rating Details | |
2023-07-11 03:12:09 -0500 | Rating Details |